Abstract
Aberrant vascular smooth muscle cell (VSMC) migration has been implicated in a variety of vascular disorders, while the signal pathways governing this process remain unclear. Here, we investigated whether miRNAs, which are strong post-transcriptional regulators of gene expression, could alter VSMC migration. We detected the expression of miR-4463 in the plasma of patients with atherosclerosis and in human aortic smooth muscle cells under hypoxia-ischemia condition, and investigated the migration effect and its downstream pathways. The results have shown that whether in clinical AS patients or hypoxic cells, the expression of miR-4463 was lower than that of normal group, then the number of migrating cells in the miR-4463 mimic intervention group was significantly decreased compared with the normal group and miR-4463 inhibitor instead. Furthermore, the expression of angiomotin (AMOT) in gastrocnemius muscle and femoral artery of patients was significantly higher than that of the control group. The protein level of AMOT in miR-4463 mimic intervention group was significantly decreased, and its level was reversed by inhibiting miR-4463. In summary, these results indicate that miR-4463 is a novel modulator of VSMC migration by target...Continue Reading
References
Mar 21, 2001·The Journal of Cell Biology·B TroyanovskyL Holmgren
Jan 23, 2009·The Journal of Biological Chemistry·Ying LinChunxiang Zhang
Jul 16, 2010·Journal of Vascular Surgery·Cressida A LyonSarah Jane George
Jan 27, 2011·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ku-Chung ChenSuh-Hang Hank Juo
Sep 15, 2011·International Journal of Hypertension·Carmine SavoiaMassimo Volpe
Dec 4, 2012·International Journal of Molecular Sciences·Shan-Shan KongWei-Jin Zang
Feb 15, 2013·PloS One·Paola CastagninoRichard K Assoian
Jun 21, 2013·Molecular Medicine Reports·Shaohong DongXinyun Xu
Jun 13, 2014·BioData Mining·Yunli Wang, Youlian Pan
Mar 5, 2015·Molecular Medicine Reports·Xiaobing LiZhenjiang Liu
Mar 21, 2015·PloS One·Alok ArunCaroline M Nieberding
Jul 15, 2015·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Xiao-feng ZhuShen-ming Wang
Jul 17, 2015·International Journal of Cancer. Journal International Du Cancer·Irfete S FetahuEnikő Kállay
Sep 16, 2015·Journal of Atherosclerosis and Thrombosis·Xue-Mei HeXiang-Yu Zhou
Nov 21, 2015·Vascular Pharmacology·Cressida A LyonSarah J George
Feb 9, 2016·OncoTargets and Therapy·Wen-Dong RuanBin Zhang
Oct 26, 2016·Oncology Reports·Yan ZhangMing Zhang
Nov 23, 2016·International Journal of Cardiology·Jiajun XiaoDuan Ma
Dec 31, 2016·Development, Growth & Differentiation·Hiroshi Sasaki
Jan 18, 2017·Lipids in Health and Disease·Yee Ting LeeGary Tse
Jan 20, 2017·Biological Research·Hyang-Hee SeoKi-Chul Hwang
Jan 22, 2017·Biochemical and Biophysical Research Communications·Wei-Fang ZhangZheng Zhang
Jan 29, 2017·American Journal of Physiology. Lung Cellular and Molecular Physiology·Sherry E AdesinaRoy L Sutliff
Feb 6, 2017·Placenta·Weifang LiuLi Zou
Feb 10, 2017·PloS One·Maryam AbdollahiSusan V McLennan
Feb 12, 2017·Cancer Gene Therapy·Z ZhangQ Zhang
Feb 17, 2017·FEBS Open Bio·Ying-Ru LiZhi-Peng Jiang
Feb 16, 2018·Mediators of Inflammation·Zhiyan WangYi Wang
Citations
Feb 8, 2020·Andrologia·Zohreh HeidaryHamid Reza Khorram Khorshid
Aug 12, 2020·Journal of Cell Communication and Signaling·Jingbo ChenChaohong Li
Aug 29, 2020·Clinical and Experimental Reproductive Medicine·Su-Yeon LeeMi Kyoung Koong
Sep 26, 2019·Frontiers in Genetics·Muya ChenZhonglin Tang
Nov 28, 2020·Cell and Tissue Research·Xueqin WangXiangyu Zhou